Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SI
2726
PUT
DELISTED
Silvergate Capital Corporation
SI
| $9.1M | ﹤0.01% |
170,000
-57,500
| -25% | -$5.36M |
|
2727
AMC Entertainment Holdings
AMC
$2.23B
| $9.09M | ﹤0.01% |
67,081
+58,217
| +657% | +$8.47M |
|
2728
MasTec
MTZ
$23.9B
| $9.08M | ﹤0.01% |
126,745
-335,423
| -73% | -$26.2M |
|
|
BSKY
2729
DELISTED
Big Sky Growth Partners, Inc. Class A Common Stock
BSKY
| $9.06M | ﹤0.01% |
930,671
-131
| -0% | -$1.28K |
|
2730
Kinetik
KNTK
$4.3B
| $9.05M | ﹤0.01% |
265,180
+51,838
| +24% | +$1.92M |
|
2731
CALL
Golar LNG
GLNG
$5.36B
| $9.05M | ﹤0.01% |
397,900
+150,100
| +61% | +$3.59M |
|
|
ARNC
2732
PUT
DELISTED
Arconic Corporation
ARNC
| $9.05M | ﹤0.01% |
322,600
+37,900
| +13% | +$1.02M |
|
2733
Dolby
DLB
$5.84B
| $9.05M | ﹤0.01% |
+126,423
| New | +$9.56M |
|
2734
CALL
Hyatt Hotels
H
$17.1B
| $9.04M | ﹤0.01% |
122,300
+4,500
| +4% | +$390K |
|
|
HPX
2735
DELISTED
HPX Corp.
HPX
| $9.03M | ﹤0.01% |
904,733
-541
| -0.1% | -$5.38K |
|
2736
CALL
Alaska Air
ALK
$5.13B
| $9.02M | ﹤0.01% |
225,100
-131,000
| -37% | -$6.4M |
|
2737
CALL
Lithia Motors
LAD
$8.3B
| $9.01M | ﹤0.01% |
32,800
+2,300
| +8% | +$671K |
|
|
DOCU
2738
DocuSign
DOCU
$11.8B
| $9.01M | ﹤0.01% |
157,007
+135,295
| +623% | +$11M |
|
|
CVSA
2739
Covista Inc
CVSA
$4.49B
| $9.01M | ﹤0.01% |
250,384
+147,516
| +143% | +$4.65M |
|
2740
PUT
Invesco S&P 500 Equal Weight ETF
RSP
$100B
| $9.01M | ﹤0.01% |
67,100
+2,600
| +4% | +$380K |
|
2741
Denali Therapeutics
DNLI
$3.9B
| $9.01M | ﹤0.01% |
306,002
-445,601
| -59% | -$11.7M |
|
2742
CALL
Alcon
ALC
$35.9B
| $9M | ﹤0.01% |
128,800
-80,300
| -38% | -$5.86M |
|
2743
Cadre Holdings
CDRE
$1.46B
| $9M | ﹤0.01% |
457,416
+446,543
| +4,107% | +$10.5M |
|
2744
PUT
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$310M
| $8.99M | ﹤0.01% |
343,700
+75,000
| +28% | +$1.91M |
|
2745
CALL
Inspire Medical Systems
INSP
$1.65B
| $8.99M | ﹤0.01% |
49,200
+1,700
| +4% | +$339K |
|
2746
Macy's
M
$6.16B
| $8.99M | ﹤0.01% |
490,560
-416,528
| -46% | -$9.42M |
|
2747
CALL
Papa John's
PZZA
$799M
| $8.99M | ﹤0.01% |
107,600
-24,300
| -18% | -$2.19M |
|
2748
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.96B
| $8.98M | ﹤0.01% |
+494,394
| New | +$9.61M |
|
|
ICVX
2749
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $8.98M | ﹤0.01% |
1,567,708
+84,336
| +6% | +$658K |
|
|
GTPA
2750
DELISTED
Gores Technology Partners, Inc. Class A Common Stock
GTPA
| $8.98M | ﹤0.01% |
916,870
+28
| +0% | +$274 |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.